Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Radiat Oncol. 2013 Mar 24;8:71. doi: 10.1186/1748-717X-8-71.
The delivery of post-mastectomy radiation therapy (PMRT) can be challenging for patients with left sided breast cancer that have undergone mastectomy. This study investigates the use of protons for PMRT in selected patients with unfavorable cardiac anatomy. We also report the first clinical application of protons for these patients.
Eleven patients were planned with protons, partially wide tangent photon fields (PWTF), and photon/electron (P/E) fields. Plans were generated with the goal of achieving 95% coverage of target volumes while maximally sparing cardiac and pulmonary structures. In addition, we report on two patients with unfavorable cardiac anatomy and IMN involvement that were treated with a mix of proton and standard radiation.
PWTF, P/E, and proton plans were generated and compared. Reasonable target volume coverage was achieved with PWTF and P/E fields, but proton therapy achieved superior coverage with a more homogeneous plan. Substantial cardiac and pulmonary sparing was achieved with proton therapy as compared to PWTF and P/E. In the two clinical cases, the delivery of proton radiation with a 7.2 to 9 Gy photon and electron component was feasible and well tolerated. Akimbo positioning was necessary for gantry clearance for one patient; the other was treated on a breast board with standard positioning (arms above her head). LAO field arrangement was used for both patients. Erythema and fatigue were the only noted side effects.
Proton RT enables delivery of radiation to the chest wall and regional lymphatics, including the IMN, without compromise of coverage and with improved sparing of surrounding normal structures. This treatment is feasible, however, optimal patient set up may vary and field size is limited without multiple fields/matching.
对于接受过乳房切除术的左侧乳腺癌患者,实施乳房切除术后放射治疗(PMRT)可能具有挑战性。本研究调查了在具有不利心脏解剖结构的选定患者中使用质子进行 PMRT 的情况。我们还报告了这些患者首次应用质子的临床情况。
对 11 例患者进行了质子、部分宽切线光子场(PWTF)和光子/电子(P/E)场的计划。制定计划的目的是在最大程度地保护心脏和肺结构的同时,实现目标体积 95%的覆盖率。此外,我们还报告了两例具有不利心脏解剖结构和 IMN 受累的患者,他们接受了质子和标准放疗的混合治疗。
生成并比较了 PWTF、P/E 和质子计划。PWTF 和 P/E 场可实现合理的靶区覆盖,但质子治疗可实现更均匀的计划,从而获得更好的覆盖。与 PWTF 和 P/E 相比,质子治疗可实现大量的心脏和肺保护。在两个临床病例中,7.2 至 9Gy 光子和电子成分的质子放射治疗的实施是可行的,且患者耐受良好。一名患者因龙门架清除需要 akimbo 定位;另一名患者在标准定位(手臂举过头顶)的乳房板上接受治疗。两名患者均采用 LAO 场排列。仅观察到红斑和疲劳等不良反应。
质子 RT 可在不影响覆盖范围的情况下,将放射治疗递送至胸壁和区域淋巴结,包括 IMN,并改善周围正常结构的保护。这种治疗是可行的,但是,最佳的患者设置可能会有所不同,并且在没有多个场/匹配的情况下,场大小会受到限制。